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Actin plays a central role in the eukary-
otic cytoskeleton and interacts with
a large number of proteins (1). The ac-
tin-binding domains in these proteins
have been classified into different
groups based on structural similarity.
A repeat of two calponin-homology
domains (designated CH1-CH2) con-
stitutes one major class of low-affinity
actin-binding domains (ABDs) (2,3).
Despite the abundance and importance
of this domain, the mechanism by
which it binds F-actin is intensely de-
bated. There are two competing struc-
tural models, closed (or compact) and
open (or extended), referring to the rel-
ative position of the two CH domains
upon binding to filamentous actin
(F-actin). All the structures of isolated
ABDs show the two CH domains
tightly packed against one another,
i.e., in a closed conformation. How-
ever, in two of the structures (utrophin
and dystrophin), the closed conforma-
tion results from domain swapping be-
tween two monomers in the crystal;
this is considered to be a crystallization
artifact because both ABDs appear to
be monomeric in solution.
The prevalence of the closed confor-
mation in crystal structures and the fact
that hydrophobic amino acids are bur-
ied at the interface between CH do-
mains has led to the notion that this
conformation is stable and may be pre-
served upon weak-affinity binding tohttp://dx.doi.org/10.1016/j.bpj.2012.09.037
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emerged as a result of conflicting elec-
tron-microscopic studies, centering on
whether the ABD is closed or open
when bound to actin. Furthermore,
the domain-swapped structures of utro-
phin and dystrophin indicate that these
two ABDs can be at least transiently
open. Because of such discrepancies,
independent methods are needed to
characterize the conformation of tan-
dem CH domains in solution and in
their F-actin-bound form.
An article in this issue of Biophysi-
cal Journal by Singh and Mallela (4)
brings the technique of pyrene excimer
fluorescence to bear on the question of
the solution conformation of the tan-
dem CH domain in dystrophin. The
technique is simple in principle.
When two pyrene molecules are close
in space, their aromatic rings stack
against one another resulting in the
formation of an excimer and the ap-
pearance of a new fluorescence band
(5). Labeling cysteines in the CH
domains with pyrene can then deter-
mine whether or not the two positions
are proximal from the observation of
excimer fluorescence band. Taking
advantage of two endogenous cysteine
residues in the dystrophin ABD se-
quence, one in each CH domain, the
authors label each with pyrene, and
look for the signature pyrene excimer
fluorescence band. They conclude
that contrary to the domain-swapped
crystal structure (6), dystrophin’s
ABD is monomeric in solution and
adopts a closed conformation affording
significant interactions between the
individual CH domains. Excimer
fluorescence is also observed in the
F-actin-bound form, implying that the
ABD remains in a close conformation
when bound to F-actin. This technique
thus elegantly demonstrates that the
free and F-actin bound conformation
of dystrophin’s ABD is closed.
The study raises interesting ques-
tions concerning the conformational
preferences of dystrophin versus
utrophin. Deficiency of dystrophin is
associated with Duchenne’s musculardystrophy, whereas deficiency of utro-
phin has less severe consequences.
Utrophin biosynthesis is elevated in
Duchenne patients. Contrary to the
tandem CH domains in dystrophin,
those of utrophin appear to bind F-
actin in an open form, as revealed by
an incisive spin-spin double-labeling
experiment (7). Because the CH do-
mains in the two proteins share 82%
sequence similarity and 73% identity,
understanding how the two proteins
achieve such different conformational
preferences is thus of interest in eluci-
dating their biological functions.
Do these conformational prefer-
ences distinguish the actin-binding sur-
faces of the two proteins? The
relatively low-resolution pyrene exci-
mer experiment used by the authors
does not provide quantitative distance
information. More quantitative mea-
surements, using, for instance, fluores-
cence resonance energy transfer and
spin-labeling (i.e., DEER), can be
used in the future to address this ques-
tion and to investigate mutations of the
actin-binding domain of dystrophin
that are associated with disease (8).
The results could shed needed light
on the longer-term possibility of
designing smaller stable proteins that
might offer some treatment for muscu-
lar dystrophy (9). The question of
open-versus-closed conformations is
of interest for other CH domains, and
the results of Singh and Mallela
contribute importantly to the ongoing
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